SARAH NANCE: Open Payments
NPI 1841967288 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,888 in 140 payments from 21 companies in 2025. Trend: 2023 $1,767 · 2024 $2,563 · 2025 $2,888
Food & beverage: $2,888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $788 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $399 |
| GENZYME CORPORATION | 4 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $157 |
| Phathom Pharmaceuticals, Inc. | 10 | $152 |
| Madrigal Pharmaceuticals | 10 | $149 |
| Celltrion USA Inc. | 8 | $141 |
| Medtronic, Inc. | 1 | $130 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Amgen Inc. | 1 | $103 |
Products named: ENTYVIO, SKYRIZI, RINVOQ, DUPIXENT, XIFAXAN, VOQUEZNA, REZDIFFRA, VEGZELMA.
Industry payments across OH — which companies pay providers there.
